Login / Signup
Off-label therapy targeting pathogenic inflammation in COVID-19.
Luigina Romani
Carlo Tomino
Paolo Puccetti
Enrico Garaci
Published in:
Cell death discovery (2020)
Keyphrases
</>
coronavirus disease
sars cov
oxidative stress
cancer therapy
respiratory syndrome coronavirus
stem cells
drug delivery
mesenchymal stem cells
bone marrow
cell therapy
smoking cessation